BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 15705012)

  • 1. A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients.
    Iwasaki K; Satoh-Nakagawa T; Maruyama M; Monma Y; Nemoto M; Tomita N; Tanji H; Fujiwara H; Seki T; Fujii M; Arai H; Sasaki H
    J Clin Psychiatry; 2005 Feb; 66(2):248-52. PubMed ID: 15705012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Yi-Gan San on psychiatric symptoms and sleep structure at patients with behavioral and psychological symptoms of dementia.
    Shinno H; Inami Y; Inagaki T; Nakamura Y; Horiguchi J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):881-5. PubMed ID: 18243460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized cross-over study of a traditional Japanese medicine (kampo), yokukansan, in the treatment of the behavioural and psychological symptoms of dementia.
    Mizukami K; Asada T; Kinoshita T; Tanaka K; Sonohara K; Nakai R; Yamaguchi K; Hanyu H; Kanaya K; Takao T; Okada M; Kudo S; Kotoku H; Iwakiri M; Kurita H; Miyamura T; Kawasaki Y; Omori K; Shiozaki K; Odawara T; Suzuki T; Yamada S; Nakamura Y; Toba K
    Int J Neuropsychopharmacol; 2009 Mar; 12(2):191-9. PubMed ID: 19079814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled clinical trial of the Chinese herbal medicine "ba wei di huang wan" in the treatment of dementia.
    Iwasaki K; Kobayashi S; Chimura Y; Taguchi M; Inoue K; Cho S; Akiba T; Arai H; Cyong JC; Sasaki H
    J Am Geriatr Soc; 2004 Sep; 52(9):1518-21. PubMed ID: 15341554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of risperidone, yokukansan, and fluvoxamine for the treatment of behavioral and psychological symptoms of dementia: a blinded, randomized trial.
    Teranishi M; Kurita M; Nishino S; Takeyoshi K; Numata Y; Sato T; Tateno A; Okubo Y
    J Clin Psychopharmacol; 2013 Oct; 33(5):600-7. PubMed ID: 23948783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of yokukansan on the behavioral and psychological symptoms of dementia in elderly patients with Alzheimer's disease.
    Monji A; Takita M; Samejima T; Takaishi T; Hashimoto K; Matsunaga H; Oda M; Sumida Y; Mizoguchi Y; Kato T; Horikawa H; Kanba S
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):308-11. PubMed ID: 19138715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized double-blind placebo-controlled multicenter trial of Yokukansan for neuropsychiatric symptoms in Alzheimer's disease.
    Furukawa K; Tomita N; Uematsu D; Okahara K; Shimada H; Ikeda M; Matsui T; Kozaki K; Fujii M; Ogawa T; Umegaki H; Urakami K; Nomura H; Kobayashi N; Nakanishi A; Washimi Y; Yonezawa H; Takahashi S; Kubota M; Wakutani Y; Ito D; Sasaki T; Matsubara E; Une K; Ishiki A; Yahagi Y; Shoji M; Sato H; Terayama Y; Kuzuya M; Araki N; Kodama M; Yamaguchi T; Arai H
    Geriatr Gerontol Int; 2017 Feb; 17(2):211-218. PubMed ID: 26711658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study.
    Miyaoka T; Furuya M; Yasuda H; Hayashida M; Nishida A; Inagaki T; Horiguchi J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):761-4. PubMed ID: 18201810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of yokukansan on behavioral and psychological symptoms of vascular dementia: an open-label trial.
    Nagata K; Yokoyama E; Yamazaki T; Takano D; Maeda T; Takahashi S; Terayama Y
    Phytomedicine; 2012 Apr; 19(6):524-8. PubMed ID: 22421528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment with Yokukansan for behavioral and psychological symptoms of Parkinsonian dementia.
    Kawanabe T; Yoritaka A; Shimura H; Oizumi H; Tanaka S; Hattori N
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):284-7. PubMed ID: 19948198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yi-gan san for the treatment of borderline personality disorder: an open-label study.
    Miyaoka T; Furuya M; Yasuda H; Hayashia M; Inagaki T; Horiguchi J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):150-4. PubMed ID: 17765378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yi-gan san as adjunctive therapy for treatment-resistant schizophrenia: an open-label study.
    Miyaoka T; Furuya M; Yasuda H; Hayashida M; Nishida A; Inagaki T; Horiguchi J
    Clin Neuropharmacol; 2009; 32(1):6-9. PubMed ID: 19471183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Yokukansan on behavioral and psychological symptoms of dementia in regular treatment for Alzheimer's disease.
    Okahara K; Ishida Y; Hayashi Y; Inoue T; Tsuruta K; Takeuchi K; Yoshimuta H; Kiue K; Ninomiya Y; Kawano J; Yoshida K; Noda S; Tomita S; Fujimoto M; Hosomi J; Mitsuyama Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):532-6. PubMed ID: 20170698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yokukansan in the Treatment of Behavioral and Psychological Symptoms of Dementia: An Updated Meta-Analysis of Randomized Controlled Trials.
    Matsunaga S; Kishi T; Iwata N
    J Alzheimers Dis; 2016 Sep; 54(2):635-43. PubMed ID: 27497482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of behavioral and psychological symptoms of Alzheimer-type dementia with Yokukansan in clinical practice.
    Hayashi Y; Ishida Y; Inoue T; Udagawa M; Takeuchi K; Yoshimuta H; Kiue K; Ninomiya Y; Kawano J; Sameshima T; Kawahara T; Goto I; Shudo K; Kurayama S; Nakamura J; Okahara K; Mitsuyama Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):541-5. PubMed ID: 20184936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yi-gan san for treatment of charles bonnet syndrome (visual hallucination due to vision loss): an open-label study.
    Miyaoka T; Furuya M; Kristian L; Wake R; Kawakami K; Nagahama M; Kawano K; Ieda M; Tsuchie K; Horiguchi J
    Clin Neuropharmacol; 2011; 34(1):24-7. PubMed ID: 21164340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined therapy of Di-Huang-Yi-Zhi with Donepezil in patients with Parkinson's disease dementia.
    Gu C; Shen T; An H; Yuan C; Zhou J; Ye Q; Liu T; Wang X; Zhang T
    Neurosci Lett; 2015 Oct; 606():13-7. PubMed ID: 26297124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Behavioral and psychological symptoms in elderly people with cognitive impairment. Differences between assessment at home and at an adult day-care facility].
    Hashidate H; Harada K; Asakawa Y; Yamagami T; Nihei K; Kaneya S; Yoshii C
    Nihon Koshu Eisei Zasshi; 2012 Aug; 59(8):532-43. PubMed ID: 23066632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Yi-Gan-san on the psychiatric behavior of children and adolescents with Tourette's Syndrome: A randomized, double-blind, controlled preliminary study.
    Huang CH; Liao WL; Lee DY; Chou IC; Wang MY; Hsieh CL
    J Ethnopharmacol; 2022 May; 290():115098. PubMed ID: 35182665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement in delusions and hallucinations in patients with dementia with Lewy bodies upon administration of yokukansan, a traditional Japanese medicine.
    Iwasaki K; Kosaka K; Mori H; Okitsu R; Furukawa K; Manabe Y; Yoshita M; Kanamori A; Ito N; Wada K; Kitayama M; Horiguchi J; Yamaguchi S; Takayama S; Fukuhara R; Ouma S; Nakano S; Hashimoto M; Kinoshita T
    Psychogeriatrics; 2012 Dec; 12(4):235-41. PubMed ID: 23279145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.